This is a type of treatment that uses light, like a laser, to generate heat in a specific part of the body. This heat can help treat certain types of cancer or other conditions. It often involves using special materials to help the light convert into heat.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Photothermal therapy uses light, usually from a near-infrared laser, to heat a small area of tissue until the cells there are destroyed. It is being developed mainly as a way to treat tumors from the inside without removing them surgically. The idea is to concentrate heat where the disease is while sparing the tissue around it. There are two broad versions. In the simpler one, laser light delivered through a thin fiber is absorbed by the tissue itself and turns into heat. In the newer, experimental version, a person first receives tiny light-absorbing particles, such as gold-coated nanoparticles, or a dye. These collect preferentially in the tumor, so when the laser is applied, the tumor heats more than the surrounding tissue and a lower laser power can be used. It differs from photodynamic therapy, which uses a light-activated drug to cause chemical rather than heat damage.
Laser heat treatment without added particles is already used, guided by magnetic resonance imaging (MRI), for selected tumors in places such as the liver, prostate and brain, usually when a growth is small and well defined. Particle-enhanced photothermal therapy is mostly available only within clinical trials. The most studied human use of the particle approach is focal treatment of prostate cancer: destroying a single, clearly visible area of low- or intermediate-risk cancer rather than removing or irradiating the whole prostate. Small early studies have also tried it in lung, head and neck and advanced breast cancers. It is not a standard option for widespread cancer, and it is generally not suited to tumors that cannot be reached by the light or seen clearly on imaging.
Treatment is planned from detailed imaging so the team can map the target, the margin of healthy tissue to include and the structures to avoid. In the best-described prostate trial, it took place over two days. On the first day, the nanoparticles were given through an intravenous drip. On the second, under general anesthesia, thin needles guided by MRI and ultrasound were placed through the skin between the scrotum and anus, and a laser fiber was passed through each to heat the tumor in short bursts. Temperature probes and cooling fluid protected the urethra and rectum, and people usually went home the same day. For laser-only treatment, the fiber is placed through a small opening and the heating is watched in real time on MRI. The details, including anesthesia and how long the procedure takes, depend on the organ being treated.
The treated tissue is destroyed in place rather than removed. In the prostate trial, no one had a serious complication, but some people need a urinary catheter for a short time if they have trouble passing urine at first. Swelling and inflammation in the treated area settle over the following weeks as the destroyed tissue is replaced by scar. Follow-up matters as much as the procedure. Imaging soon afterward checks that the intended area was covered, and repeat MRI and biopsy months later show whether any cancer remains. In the prostate trial, some treated areas still contained cancer at three months, and a few people had cancer elsewhere in the gland, so further treatment or ongoing monitoring can be needed.
Most research on particle-enhanced photothermal therapy comes from laboratory and animal studies. Human data are limited to a few small early trials, and no particle-based photothermal treatment has become standard care. In the best-reported human study, 15 men with localized prostate cancer were treated with gold nanoshells and laser heat. A year later, biopsies of the treated areas found no cancer in 14 of 16 treated lesions, and urinary and sexual function scores had not changed significantly at three months. These results are encouraging, but the study had no comparison group and short follow-up, so it cannot show whether this approach controls cancer as well as surgery, radiation or active monitoring over the long term. Laser-only ablation has a longer track record for selected small tumors, though it too is generally compared with other local treatments rather than proven superior to them.
The main risk is heat reaching healthy tissue next to the target, which can cause burns, pain, swelling or damage to nearby structures; in the prostate this includes the urethra, rectum and the nerves involved in erections. Careful planning, temperature monitoring and cooling reduce but do not remove that risk. Treatment can also miss part of a tumor, especially one that is larger than expected on imaging or close to a large blood vessel that carries heat away. With particle-enhanced treatment, the infusion itself occasionally causes reactions such as itching or a brief burning feeling in the chest or upper abdomen. How the particles behave in the body over many years is not yet fully known. Because laser light penetrates only about a centimeter through tissue, deeper tumors need needles or a scope to deliver it. Access is limited to specialized centers and research studies.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Photothermal Therapy, what's helped you, or ask the community a question.